Daniel Burrage
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 10
-
- Pharmacy and Medical Practices 4
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Nidhi Sofat (1 shared paper)Emma H. Baker (9 shared papers)Darmiga Thayabaran (1 shared paper)D Lonsdale (2 shared papers)Andrew William Hitchings (2 shared papers)Selma Audi (1 shared paper)Jamie J. Coleman (1 shared paper)Sarah Katie Pontefract (1 shared paper)
- Journals
- The Lancet (7 papers)European Heart Journal - Cardiovascular Pharmacotherapy (2 papers)British Journal of Clinical Pharmacology (2 papers)PLoS ONE (2 papers)Thorax (2 papers)
- Partner nations
- United KingdomAustriaNepal
In The Last Decade
Daniel Burrage
24 papers receiving 1.8k citations
Daniel Burrage's Hit Papers
Peers
Comparison fields: 5 of 91
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 35
- Internal Medicine 27
- Geriatrics and Gerontology 18
- Pharmacology 45
Countries citing papers authored by Daniel Burrage
This map shows the geographic impact of Daniel Burrage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Burrage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Burrage more than expected).
Fields of papers citing papers by Daniel Burrage
This network shows the impact of papers produced by Daniel Burrage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Burrage. The network helps show where Daniel Burrage may publish in the future.
Co-authors
The 15 scholars most cited alongside Daniel Burrage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | 2020 | 57 | |
| 8 | 2018 | 50 | |
| 9 | 2021 | 34 | |
| 10 | 2023 | 25 | |
| 11 | 2024 | 24 | |
| 12 | 2019 | 23 | |
| 13 | 2021 | 18 | |
| 14 | 2018 | 11 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2014 | 2 | |
| 20 | 2014 | 2 |
About Daniel Burrage
Daniel Burrage is a scholar working on Infectious Diseases, Pharmacology, Geriatrics and Gerontology, Pulmonary and Respiratory Medicine and Neurology, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Pharmacy and Medical Practices (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Acute Ischemic Stroke Management (2 papers), Innovations in Medical Education (2 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Health Services Management and Policy (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (35 citations), Internal Medicine (27 citations), Geriatrics and Gerontology (18 citations) and Pharmacology (45 citations). Daniel Burrage has collaborated with scholars based in United Kingdom, Austria and Nepal. Frequent co-authors include Nidhi Sofat, Emma H. Baker, Darmiga Thayabaran, D Lonsdale, Andrew William Hitchings, Selma Audi, Jamie J. Coleman, Sarah Katie Pontefract, Paul Jones and James William Dodd. Their work appears in journals such as The Lancet, European Heart Journal - Cardiovascular Pharmacotherapy, British Journal of Clinical Pharmacology, PLoS ONE and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.